Related Experiment Video

Updated: Jun 30, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

Quality of Life and Glucose Regulation in Pediatric Patients with Type 1 Diabetes: A Study in the Ningxia Hui

Hua Bai1, Na He2, Yan Zhang3

  • 1Department of Pediatrics, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China.

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|March 18, 2024
PubMed

Insights

Pediatric patients with type 1 diabetes in Ningxia have poor glucose control and quality of life. Enhancing glucose regulation through diet, monitoring, and education is crucial for improving outcomes.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Type 1 diabetes (T1DM) significantly impacts children's quality of life (QOL).
  • Effective glycemic control is essential for managing T1DM and preventing complications.
  • Understanding regional disparities in T1DM management is vital for targeted interventions.

Purpose of the Study:

  • To assess the quality of life (QOL) in pediatric patients with type 1 diabetes (T1DM).
  • To evaluate the current status of plasma glucose regulation in children with T1DM in the Ningxia Hui autonomous region.
  • To identify factors influencing QOL and glycemic control in this population.

Main Methods:

  • A cohort of 136 pediatric patients with T1DM was studied.
  • Data collected included general information, QOL questionnaires, and HbA1c levels.
  • Factors affecting glucose control and QOL were investigated.

Main Results:

  • Mean HbA1c was 8.7%, with 43.3% of patients showing poor glycemic control.
  • Disease duration, age, glucose monitoring frequency, CGM use, DKA, and maternal education influenced glucose control.
  • Poor glycemic control, DKA, and inadequate health education negatively impacted QOL.

Conclusions:

  • Glycemic regulation in pediatric T1DM patients in Ningxia is suboptimal, affecting QOL.
  • Comprehensive strategies including dietary management, rigorous glucose monitoring, and enhanced health education are needed.
  • Improving glucose control is key to enhancing QOL for children with T1DM.
Abstract

Keywords:
QOLcurrent status of regulation of plasma glucose concentrationinfluencing factorstype 1 diabetes

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.5K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
533
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
259
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
281
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
170